Celebrex
Celebrex is a pharmaceutical drug with 25 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 18 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
78.3%
18 of 23 finished
21.7%
5 ended early
0
trials recruiting
25
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas
Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery
Pre vs Post Block in Total Knee Arthroplasty (TKA)
Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial
Clinical Trials (25)
Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas
Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery
Pre vs Post Block in Total Knee Arthroplasty (TKA)
Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial
Different Kinds of Acupuncture Treatment for Knee Osteoarthritis
Efficacy of Multimodal Analgesia Following Hip Arthroscopy
MAST Trial: Multi-modal Analgesic Strategies in Trauma
Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women
Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation
Celebrex and Metformin for Postoperative Hepatocellular Carcinoma
Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis
Effect of Celecoxib on Transitional Pain After Outpatient Surgery
Safety of Celecoxib in Patients With Crohn's Disease
Decreasing Narcotics in Advanced Pelvic Surgery
The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle
Celebrex (Celecoxib) Treatment of Laryngeal Papilloma
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 25